Asked by: Lord Bourne of Aberystwyth (Conservative - Life peer)
Question to the Department for Environment, Food and Rural Affairs:
To ask His Majesty's Government what steps they are taking to address public concerns concerning (1) the quality of drinking water, and (2) the discharge of untreated waste into the sea, rivers and lakes.
Answered by Lord Douglas-Miller - Parliamentary Under-Secretary (Department for Environment, Food and Rural Affairs)
It is important not to conflate the quality of raw water and drinking water. Drinking water quality in England is of an exceptionally high standard and among the best in the world. Compliance with drinking water quality standards has been consistently high for a number of years, with a rate of 99.97% in 2022.
The Government published the Plan for Water in April 2023 – our comprehensive strategy for managing our water environment. It brings together the significant steps we have already taken with a suite of new policy actions. It aims to change the way that we manage water, improve water quality, and continue to secure our water supply through increased investment, stronger regulation and enforcement.
The Government is clear that the amount of sewage discharged into our waters is unacceptable. The Storm Overflow Discharge Reduction Plan (SODRP) sets out stringent targets to protect people and the environment; and prioritises for early action areas used for bathing, for growing shellfish or with high ecological importance. The SODRP will drive £60 billion investment between now and 2050 to improve storm overflows, the largest infrastructure programme in water company history.
We will not let companies get away with illegal activity and where breaches are found, the regulators will not hesitate to hold companies to account.
The recent cryptosporidium outbreak in Brixham is extremely unfortunate and it is a horrific experience for the people who have been made ill. The Drinking Water Inspectorate is actively investigating the cause, extent and actions of the company, and will take actions including enforcement action in due course to prevent this type of event happening again.
Thankfully, these events are very rare, and elsewhere consumers should continue to have confidence in their high quality drinking water.
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will undertake a study on trends in alcohol use among young people.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England holds several data sources covering alcohol use for people aged under 18 years old, including the Smoking, Drinking and Drug Use among Young People survey. This data is collected every two years, and the next survey report is due Autumn 2024, and will include 2023 survey data.
The guidance from England’s Chief Medical Officer for healthcare professionals is clear, an alcohol-free childhood is the healthiest and best option. The Department promotes this through online platforms such as the NHS.UK website, and the Talk to FRANK online resource. Local authorities promote these guidelines as part of their public health duties.
Alcohol or drug dependence is rare in children and young people under the age of 18 years old, although they may be drinking problematically. For those that do need support, the Department has allocated £532 million of additional funding through to 2024/25 to support improvements in treatment, including facilitating 5,000 more young people into age-appropriate alcohol and drug treatment.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, on what date NHS England informed patients receiving the Oxford-AstraZeneca Covid-19 vaccine that there were safety risks of vaccine-induced thrombosis with thrombocytopenia associated with the vaccine.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
To ensure informed consent was given by patients who received the AstraZeneca COVID-19 vaccine, all vaccination sites were instructed to follow consent guidance in line with the recommendations set out in chapter two of the UK Health Security Agency Green Book on vaccinations and immunisations.
Healthcare organisations administering any COVID-19 vaccinations are responsible for drawing up their own policies for obtaining informed consent, and health professionals overseeing or administering COVID-19 vaccines are responsible for ensuring that valid consent has been obtained. This would normally involve a discussion with the clinician prior to the administration of the vaccine, and individuals will also have had access to guides and patient information leaflets which provided details about the vaccine, how it is administered, possible side effects, and other warnings and precautions to take.
Regarding the very rare adverse events of concurrent thrombosis and thrombocytopenia associated with the AstraZeneca COVID-19 vaccine, NHS England notified healthcare organisations administering the COVID-19 vaccinations immediately following the updated advice from the independent Joint Committee on Vaccination and Immunisation published on 7 April 2021, and then again following updated advice on 7 May 2021. In these updates, sent via system letters, NHS England set out the next steps for healthcare organisations and clinicians, including on the consent process.
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps NHS England took to ensure that informed consent was given by recipients of the Oxford-AstraZeneca covid-19 vaccine.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
To ensure informed consent was given by patients who received the AstraZeneca COVID-19 vaccine, all vaccination sites were instructed to follow consent guidance in line with the recommendations set out in chapter two of the UK Health Security Agency Green Book on vaccinations and immunisations.
Healthcare organisations administering any COVID-19 vaccinations are responsible for drawing up their own policies for obtaining informed consent, and health professionals overseeing or administering COVID-19 vaccines are responsible for ensuring that valid consent has been obtained. This would normally involve a discussion with the clinician prior to the administration of the vaccine, and individuals will also have had access to guides and patient information leaflets which provided details about the vaccine, how it is administered, possible side effects, and other warnings and precautions to take.
Regarding the very rare adverse events of concurrent thrombosis and thrombocytopenia associated with the AstraZeneca COVID-19 vaccine, NHS England notified healthcare organisations administering the COVID-19 vaccinations immediately following the updated advice from the independent Joint Committee on Vaccination and Immunisation published on 7 April 2021, and then again following updated advice on 7 May 2021. In these updates, sent via system letters, NHS England set out the next steps for healthcare organisations and clinicians, including on the consent process.
Asked by: George Galloway (Workers Party of Britain - Rochdale)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking to help tackle teenage drug addiction.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
Alcohol or drug dependence is rare in young people under the age of 18 years old, although they may be drinking problematically. The most effective and sustainable approach to reducing alcohol and drug harms in young people is by giving them the best start in life, the best education possible, and keeping them safe, well, and happy.
Statutory guidance on relationships, sex, and health education requires all primary and secondary school pupils to be taught the key facts and risks of alcohol and drug use, as well as how to manage influences and pressure, and keep themselves healthy and safe. The Department has worked with the PSHE Association to develop the lesson plans on alcohol and is currently commissioning an update of the resources, to be published later this year. Current resources are available at the following link:
https://pshe-association.org.uk/drugeducation
Through the cross-Government Drug Strategy, the Department has allocated £532 million of additional funding through to 2024/25, to support improvements in alcohol and drug treatment, including facilitating 5,000 more young people into age-appropriate treatment by 2024/25. Local authorities can also invest their allocation in options from a menu of interventions, some of which include strengthening the services available to young people and families.
The Government also has an information and advice service called Talk to FRANK, which aims to reduce alcohol and drug use and its harms by providing awareness to young people, parents and concerned others:
Asked by: Nick Fletcher (Conservative - Don Valley)
Question to the Department for Transport:
To ask the Secretary of State for Transport, what steps his Department is taking to help ensure that cycle lanes are not a danger to (a) visually impaired and (b) blind pedestrians.
Answered by Guy Opperman - Parliamentary Under-Secretary (Department for Transport)
Design guidance for cycle infrastructure issued by the Department for Transport sets out that there should be separation of pedestrian and cycle infrastructure wherever possible. This guidance was developed in collaboration with stakeholders, including disability groups.
The Department for Transport established Active Travel England (ATE) to up-skill local authorities, enabling the installation of changes that are well thought through for all modes of travel, and disseminating best practice. As part of this, ATE has recently published a suite of design assistance and scheme review tools to support the development of accessible active travel schemes. The agency has also commissioned West Midlands Combined Authority to undertake research into crossing detection systems.
ATE will continue to work with organisations representing blind and visually impaired people to improve standards and further reduce the rare occasions that collisions occur.
Asked by: Pauline Latham (Conservative - Mid Derbyshire)
Question to the Department for Business and Trade:
To ask the Secretary of State for Business and Trade, what steps she is taking to encourage rare earth magnet producers to the UK.
Answered by Alan Mak - Minister of State (Department for Business and Trade) (jointly with the Cabinet Office)
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Asked by: Lord Jackson of Peterborough (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to address complication rates identified in the Office for Health Improvement and Disparities statistics published 23 November 2023 (1) for women under 20 in home and clinical settings, and (2) for those who had abortions after more than ten weeks gestation in a clinical setting.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department’s comparison of statistics on abortion complications in England, using data from the Abortion Notification System, compared to data on hospital admissions for abortion complications from Hospital Episode Statistics for the years 2017 to 2021, found that women under 20 years old had the lowest complication rates of any age group.
Abortion continues to be a very safe procedure for which major complications are rare at all gestations. However, it is known that the risk of complications increases at higher gestations. The Department works closely with NHS England, the Care Quality Commission, and abortion providers to ensure that abortions are provided safely, in accordance with the legal framework set by the Abortion Act 1967.
It is a legal requirement under the 1967 Abortion Act that the Chief Medical Officer must be notified of all abortions within 14 days of the procedure. The Department provides the HSA4 abortion notification form for this purpose. HSA4 forms record known complications, up until the time of the patient’s discharge from the abortion service.
To consider the completeness of abortion complications data submitted via abortion notifications, the Department committed to publishing a one-time analysis comparing data from the Department’s Abortion Notification System and the Hospital Episode Statistics. This was published in November 2023. The Department is inviting views on abortion statistics for England and Wales, including the future publication of abortion complications data, via an online user engagement survey and via email. We welcome responses from abortion providers and all interested parties on this matter.
Asked by: Lord Jackson of Peterborough (Conservative - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government what steps they are taking to ensure statistics on abortion complications are accurately collected and analysed to develop policies to improve women's health.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department’s comparison of statistics on abortion complications in England, using data from the Abortion Notification System, compared to data on hospital admissions for abortion complications from Hospital Episode Statistics for the years 2017 to 2021, found that women under 20 years old had the lowest complication rates of any age group.
Abortion continues to be a very safe procedure for which major complications are rare at all gestations. However, it is known that the risk of complications increases at higher gestations. The Department works closely with NHS England, the Care Quality Commission, and abortion providers to ensure that abortions are provided safely, in accordance with the legal framework set by the Abortion Act 1967.
It is a legal requirement under the 1967 Abortion Act that the Chief Medical Officer must be notified of all abortions within 14 days of the procedure. The Department provides the HSA4 abortion notification form for this purpose. HSA4 forms record known complications, up until the time of the patient’s discharge from the abortion service.
To consider the completeness of abortion complications data submitted via abortion notifications, the Department committed to publishing a one-time analysis comparing data from the Department’s Abortion Notification System and the Hospital Episode Statistics. This was published in November 2023. The Department is inviting views on abortion statistics for England and Wales, including the future publication of abortion complications data, via an online user engagement survey and via email. We welcome responses from abortion providers and all interested parties on this matter.
Asked by: Lord Hunt of Kings Heath (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government whether they intend to have any discussions with the National Institute for Health and Care Excellence about routinely taking into consideration the impact on the physical and mental health of the person with a rare condition and their wider family.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Institute for Health and Care Excellence (NICE) develops its guidance independently, in line with its established methods and processes, which have been developed through extensive engagement with interested parties. In developing its guidance, the NICE takes into account all physical and mental health-related costs and benefits including, where relevant, the health-related benefits to carers and the wider family.